Effect of UDCA on the New Onset Diabetes and Glucose Intolerance Induced by Statin

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1000 participants.

Also called NCT05500937

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 1,000 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05500937
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05500937. Randomized; triple masking; primary purpose treatment. Start 2021-03-01 (actual); primary completion 2023-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of UDCA on the New Onset Diabetes and Glucose Intolerance Induced by Statin
Condition
Diabetes Mellitus
Intervention (Drug)
UDCA
Lead sponsor
First Affiliated Hospital Xi'an Jiaotong University (class: other)

Record details

Record id
cardio:ct-nct05500937
Content hash
042d7ef183a68a81faf51d55e043835092ed9eaff1b334ebcbd485f70a398902